173 related articles for article (PubMed ID: 2253854)
1. [Heterogeneity of leukemic cell phenotype. II. Variants of hetero- phenotype in relation to myeloid and megakaryocytic markers of leukemia cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Frend M; Dominis M
Gematol Transfuziol; 1990 Aug; 35(8):15-8. PubMed ID: 2253854
[No Abstract] [Full Text] [Related]
2. [Heterogeneity of leukemia cell phenotype. I. Variants of hetero- phenotype in relation to myeloid and erythrocytic markers of leukemic cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Helmke M; Frend M; Bür T; Dominis M; Horitz H
Gematol Transfuziol; 1990 Aug; 35(8):9-14. PubMed ID: 2253865
[No Abstract] [Full Text] [Related]
3. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
4. DNMT3A mutations in myeloproliferative neoplasms.
Stegelmann F; Bullinger L; Schlenk RF; Paschka P; Griesshammer M; Blersch C; Kuhn S; Schauer S; Döhner H; Döhner K
Leukemia; 2011 Jul; 25(7):1217-9. PubMed ID: 21537334
[No Abstract] [Full Text] [Related]
5. Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.
Guo BB; Allcock RJ; Mirzai B; Malherbe JA; Choudry FA; Frontini M; Chuah H; Liang J; Kavanagh SE; Howman R; Ouwehand WH; Fuller KA; Erber WN
Am J Pathol; 2017 Jul; 187(7):1512-1522. PubMed ID: 28502479
[TBL] [Abstract][Full Text] [Related]
6. Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia.
Lin P; Jones D; Medeiros LJ; Chen W; Vega-Vazquez F; Luthra R
Am J Clin Pathol; 2006 Oct; 126(4):530-3. PubMed ID: 16938665
[TBL] [Abstract][Full Text] [Related]
7. Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12).
Nakamura F; Seo S; Nannya Y; Ayabe R; Takahashi W; Handa T; Arai H; Iso H; Nakamura Y; Nakamura Y; Sasaki K; Ichikawa M; Imai Y; Ogawa S; Mitani K
Int J Hematol; 2023 Sep; 118(3):388-393. PubMed ID: 36930401
[TBL] [Abstract][Full Text] [Related]
8. [Hybrid leukemia among acute childhood leukemias].
Koehler M; Bubała H
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):347-9. PubMed ID: 1437751
[TBL] [Abstract][Full Text] [Related]
9. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options.
Iurlo A; Cattaneo D; Gianelli U
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013941
[TBL] [Abstract][Full Text] [Related]
10. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia.
Berger R
Leuk Lymphoma; 1993; 11 Suppl 1():235-7. PubMed ID: 8251902
[TBL] [Abstract][Full Text] [Related]
11. The histopathology of chronic myeloproliferative diseases.
Georgii A; Buesche G; Kreft A
Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 (Cox-2) and blast cells of patients with acute leukemia.
Vincent C; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
Leuk Res; 2008 Apr; 32(4):671-3. PubMed ID: 17881051
[No Abstract] [Full Text] [Related]
13. Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Ghosh K; Madkaikar M
Leuk Lymphoma; 2016 Sep; 57(9):2195-8. PubMed ID: 26700494
[No Abstract] [Full Text] [Related]
14. Translocation (2;3) and myeloid disorders.
Kwong YL
Cancer Genet Cytogenet; 1996 Aug; 90(1):93. PubMed ID: 8780757
[No Abstract] [Full Text] [Related]
15. [Immunophenotypes on blast cells of chronic myelogenous leukemia].
Motoji T
Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336
[TBL] [Abstract][Full Text] [Related]
16. Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis.
Uchida T; Kitaura J; Nakahara F; Togami K; Inoue D; Maehara A; Nishimura K; Kawabata KC; Doki N; Kakihana K; Yoshioka K; Izawa K; Oki T; Sada A; Harada Y; Ohashi K; Katayama Y; Matsui T; Harada H; Kitamura T
Exp Hematol; 2014 May; 42(5):369-379.e3. PubMed ID: 24486648
[TBL] [Abstract][Full Text] [Related]
17. [Acute myeloid leukemia with megakaryocytic predominance and malignant megakaryocyte proliferation. Apropos of 3 cases].
Nigro M; Ascari E; Compagnoni A; Menestrina F
Ann Anat Pathol (Paris); 1979; 24(2):171-84. PubMed ID: 294156
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.
Pullarkat ST; Vardiman JW; Slovak ML; Rao DS; Rao NP; Bedell V; Said JW
Leuk Res; 2008 Nov; 32(11):1770-5. PubMed ID: 18417213
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7).
Jarmuz M; Kroll R; Przybyłowicz-Chalecka A; Ratajczak B; Gniot M; Szyfter K; Komarnicki M
Cancer Genet Cytogenet; 2010 May; 199(1):45-7. PubMed ID: 20417868
[TBL] [Abstract][Full Text] [Related]
20. Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability.
Shlush LI; Chapal-Ilani N; Adar R; Pery N; Maruvka Y; Spiro A; Shouval R; Rowe JM; Tzukerman M; Bercovich D; Izraeli S; Marcucci G; Bloomfield CD; Zuckerman T; Skorecki K; Shapiro E
Blood; 2012 Jul; 120(3):603-12. PubMed ID: 22645183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
